Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank93
3Y CAGR+114.2%
5Y CAGR+64.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+114.2%/yr
vs -10.3%/yr prior
5Y CAGR
+64.1%/yr
Recent acceleration
Acceleration
+124.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
11.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.60M | -23.1% |
| 2024 | $37.22M | +183.8% |
| 2023 | $13.11M | +350.8% |
| 2022 | $2.91M | +476.0% |
| 2021 | $505000.00 | -79.0% |
| 2020 | $2.41M | -42.0% |
| 2019 | $4.15M | -7.4% |
| 2018 | $4.49M | +6.5% |
| 2017 | $4.21M | -3.9% |
| 2016 | $4.39M | - |